Pharmaceutical market access is not easy. It can seem fickle, lengthy and very complicated. Ensuring that your medicines get to the patients that need them involves dealing with clinicians, payers, HTA bodies and internal and external stakeholders. Just as you think you understand the rules of the game, they change. Value based pricing anyone?
It is perhaps no surprise that the service community is rising to the challenge and offering a range of solutions to help organisations get their treatments to patients. They can assist in value demonstration, interpretation of policy developments and health outcomes generation. They can help you develop the right pricing model and assist in the launch sequence planning. They can also provide you with strategic consulting services or find you the people with the skills set that you need.
Here we take a look at the top market access services required by pharma together with some companies that work in this area. I hope you find it useful.
For more on pharma pricing and market access, join us at the world’s largest gathering of pharmaceutical pricing, market access and reimbursement professionals – World Pharma Pricing & Market Access Congress 2015